These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29956377)

  • 1. Usefulness of thrombopoietin receptor agonists for persistent clinically relevant thrombocytopenia after allogeneic stem cell transplantation.
    Bosch-Vilaseca A; García-Cadenas I; Roldán E; Novelli S; Barba P; Esquirol A; Valcárcel D; Martino R; Sierra J
    Eur J Haematol; 2018 Sep; 101(3):407-414. PubMed ID: 29956377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant.
    Bento L; Bastida JM; García-Cadenas I; García-Torres E; Rivera D; Bosch-Vilaseca A; De Miguel C; Martínez-Muñoz ME; Fernández-Avilés F; Roldán E; Chinea A; Yáñez L; Zudaire T; Vaz CP; Espigado I; López J; Valcárcel D; Duarte R; Cabrera R; Herrera C; González-Porras JR; Gutiérrez A; Solano C; Sampol A;
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1825-1831. PubMed ID: 31152794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.
    Hartranft ME; Clemmons AB; DeRemer DL; Kota V
    J Oncol Pharm Pract; 2017 Jan; 23(1):10-17. PubMed ID: 26471738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation.
    Tanaka T; Inamoto Y; Yamashita T; Fuji S; Okinaka K; Kurosawa S; Kim SW; Tanosaki R; Fukuda T
    Biol Blood Marrow Transplant; 2016 May; 22(5):919-24. PubMed ID: 26785333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation.
    Sun YQ; Kong Y; Zhang XH; Wang Y; Shi MM; Song Y; Kong J; Fu HX; Yan CH; Xu LP; Liu KY; Huang XJ
    Platelets; 2019; 30(8):994-1000. PubMed ID: 30569802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single-centre experience.
    Yaman Y; Elli M; Şahin Ş; Özdilli K; Bilgen H; Bayram N; Nepesov S; Anak S
    Pediatr Transplant; 2021 Aug; 25(5):e13962. PubMed ID: 33452850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
    Nash RA; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee AP; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum FR; Champlin R
    Biol Blood Marrow Transplant; 2000; 6(1):25-34. PubMed ID: 10707996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation.
    Mahat U; Rotz SJ; Hanna R
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):e65-e73. PubMed ID: 31830528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
    Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes.
    Zhang X; Fu H; Xu L; Liu D; Wang J; Liu K; Huang X
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):274-80. PubMed ID: 20854919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
    Makar RS; Zhukov OS; Sahud MA; Kuter DJ
    Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation.
    Battipaglia G; Ruggeri A; Brissot E; Mamez AC; Malard F; Belhocine R; Vekhoff A; Giannotti F; Ledraa T; Labopin M; Rubio MT; Mohty M
    Bone Marrow Transplant; 2015 Dec; 50(12):1574-7. PubMed ID: 26281029
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of Recombinant Human Thrombopoietin for the Treatment of Secondary Failure of Platelet Recovery After Allogeneic HSCT.
    Cao Y; Wang M; Shen B; Zhao F; Zhang R; Chen X; He Y; Zhai W; Ma Q; Wei J; Huang Y; Yang D; Pang A; Feng S; Jiang E; Han M
    Clin Appl Thromb Hemost; 2022; 28():10760296211068037. PubMed ID: 35019756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.
    Reid R; Bennett JM; Becker M; Chen Y; Milner L; Phillips GL; Liesveld J
    Am J Hematol; 2012 Jul; 87(7):743-5. PubMed ID: 22573520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children.
    Maximova N; Zanon D; Rovere F; Maestro A; Schillani G; Paparazzo R
    Int J Hematol; 2015 Nov; 102(5):626-32. PubMed ID: 26084627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Romiplostin may revert the thrombocytopenia in graft-versus-host disease.
    Ruiz-Delgado GJ; Lutz-Presno J; Ruiz-Argüelles GJ
    Hematology; 2011 Mar; 16(2):108-9. PubMed ID: 21418742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eltrombopag for thrombocytopenia following allogeneic hematopoietic stem cell transplantation in children.
    Masetti R; Vendemini F; Quarello P; Girardi K; Prete A; Fagioli F; Pession A; Locatelli F
    Pediatr Blood Cancer; 2020 May; 67(5):e28208. PubMed ID: 32065469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.
    Fenaux P; Muus P; Kantarjian H; Lyons RM; Larson RA; Sekeres MA; Becker PS; Orejudos A; Franklin J
    Br J Haematol; 2017 Sep; 178(6):906-913. PubMed ID: 28616874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
    Newland A; Godeau B; Priego V; Viallard JF; López Fernández MF; Orejudos A; Eisen M
    Br J Haematol; 2016 Jan; 172(2):262-73. PubMed ID: 26537623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Romiplostim resistance in secondary failure of platelet recovery.
    DeRemer DL; Katsanevas K; Bradley A; Awan FT
    J Oncol Pharm Pract; 2013 Dec; 19(4):369-72. PubMed ID: 23292974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.